Parkinson's Disease and Movement Disorders Program
At UC Irvine Health, we specialize in the diagnosis and treatment of movement disorders. Our specialists combine state-of-the-art clinical care and advanced technology in a warm and reassuring environment.
Our physicians are board-certified and fellowship-trained in treating Parkinson's disease and other movement disorders, including Huntington's disease and dystonia. We work in collaboration with physical therapists and nutrition counselors to personalize each patient's care.
Our patients also benefit from our leading-edge clinical research and access to the latest technologies. The Parkinson's Disease and Movement Disorders team belongs to several national and international research consortiums on movement disorders, including: the Parkinson’s Study Group, the Huntington’s Study Group and the Dystonia Study Group.
For more information or to schedule an appointment with our movement disorder specialists, please call 714-456-7720.
The Parkinson's Disease and Movement Disorders team diagnoses and treats the following conditions:
- Cervical dystonia (torticollis)
- Essential tremor and other forms of tremor
- Hemifacial spasm
- Huntington’s disease
- Limb spasticity (from stroke, multiple sclerosis or trauma)
- Normal pressure hydrocephalus
- Parkinson’s disease
- Parkinsonian syndromes (including progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration)
- Restless leg syndrome
- Spasmodic dysphonia
- Tic and Tourette syndrome
- Writer’s cramp (focal action dystonia)
We treat Parkinson's disease and other movement disorders by selecting therapies that best meet the needs of the individual patient. Treatments and services may include:
- Rehabilitative therapies (physical therapy, speech therapy and occupational therapy)
- Botulinum toxin (Botox) injections
- Neurosurgery, including deep brain stimulation (DBS)
When indicated, our patients may also be referred to other specialists at UC Irvine Health, including physicians in orthopaedics, gastroenterology, geriatric medicine, dermatology, neuropsychology and psychiatry, among others.
The UC Irvine Health Parkinson's Disease and Movement Disorders Program is conducting a broad range of clinical research studies to help understand these diseases, to perform early diagnosis and to improve treatment for our patients.
We are actively recruiting patients for a number of clinical trials, including:
Early Parkinson's disease, not yet medically treated:
- Study group of Isradipine as a disease modifying agent in subjects who have not started dopaminergic therapy. Learn more ›
Moderate Parkinson's disease with motor fluctuations:
- Effectiveness of extended release Amantadine (NMDA-type glutamate antagonist) to treat Levodopa-induced dyskinesia. Learn more ›
- Evaluate the efficacy of oral Istradefylline (A2 antagonist) to treat OFF time. Learn more ›
- Prospective Registry Study in Global Huntington’s disease cohort (Enroll HD). Learn more ›
- Assessing the efficacy of PF-02545920 (Phosphodiesterase inhibitor) on motor and cognitive functions in subjects with Huntington’s disease. Learn more ›
To inquire about our active research studies, please email Everylne Gomez, or call 949-824-3485.
Our UC Irvine Health team includes:
The Parkinson's Disease and Movement Disorders Program also frequently draws upon expertise from our UC Irvine Health neuroradiologists, including:
Our patients also may be seen by UC Irvine Health neuropsychologist Mina Oak, PhD.
To make an appointment with movement disorders specialists Drs. Hermanowicz, Morenkova or Phielipp, please call 714-456-7720.